BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 23, 2010
View Archived Issues
Regulus Inks $750M Pre-Target miRNA Deal with Sanofi-Aventis
Regulus Therapeutics Inc. landed its biggest partnership to date: a $750 million deal with Sanofi-Aventis Group SA aimed at discovering microRNA-based drugs against four fibrosis targets. (BioWorld Today)
Read More
Diamyd Climbs on $625M Type I Diabetes Deal with Ortho-McNeil
Read More
Metabolex, J&J Unit Sign $330M Deal for Type II Diabetes Drugs
Read More
Cadence 'Incline'd Toward Pain Market in Late-Stage Option Deal
Read More
Corrections & Clarifications
Read More
Other News To Note
Read More
Stock Movers
Read More
Clinic Roundup
Read More
Financings Roundup
Read More